These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4877738)

  • 1. Clinical trial of 6 per cent hydroxyethyl starch (a new plasma expander).
    Solanke TF
    Br Med J; 1968 Sep; 3(5621):783-5. PubMed ID: 4877738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of a new plasma expander hydroxyethyl starch.
    Lee WH; Cooper N; Weidner MG; Murner ES
    J Trauma; 1968 May; 8(3):381-93. PubMed ID: 4871744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of a new plasma expander, hydroxyethyl starch. 3. Statistical comparisons between hydroxyethyl starch and dextran 70 on blood pressure, blood analysis, electrolytes and hemostasis].
    Amakata Y; Tanaka K; Hanai A; Kosaki G
    Masui; 1972 Mar; 21(3):225-32. PubMed ID: 5064134
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hydroxyethyl starch on blood coagulation profile.
    Türkan H; Ural AU; Beyan C; Yalçin A
    Eur J Anaesthesiol; 1999 Mar; 16(3):156-9. PubMed ID: 10225163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the influences of plasma substitutes on the blood coagulation.
    Matsuura Y; Tsubokura T; Tamura M
    Jpn J Surg; 1973 Jun; 3(2):80-90. PubMed ID: 4803907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of a new plasma expander, hydroxyethyl starch (HES) on circulatory dynamics, blood coagulation and erythrocyte aggregation. 1. Studies on volunteers].
    Takeyoshi S; Yamauchi N; Hiyoshi K; Ikeda Y; Sato T
    Masui; 1971 Jul; 20(7):648-54. PubMed ID: 5105402
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of plasma expanders on coagulation and hemostasis: dextran hydroxyethyl starch, and other macromolecules revisited.
    Alexander B
    Prog Clin Biol Res; 1978; 19():293-330. PubMed ID: 78500
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of hydroxyethyl starch on blood coagulation and fibrinolysis. 1. In vitro studies].
    Matsuda T; Murakami M
    Rinsho Ketsueki; 1972 Oct; 13(5):831-4. PubMed ID: 4674858
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of hydroxyethyl starch on blood coagulation and fibrinolysis. II. In vivo studies].
    Matsuda T; Murakami S; Hashizume K
    Rinsho Ketsueki; 1972 Dec; 13(6):934-8. PubMed ID: 4675064
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch.
    Karlson KE; Garzon AA; Shaftan GW; Chu CJ
    Surgery; 1967 Oct; 62(4):670-8. PubMed ID: 6058021
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyethyl starch as a plasma expander in hemorrhagic shock.
    Murray GF; Solanke T; Thompson WL; Ballinger WF
    Surg Forum; 1965; 16():34-5. PubMed ID: 5835186
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hydroxyethyl starch on blood volume and extracellular fluid volume during hemorrhage--comparison with the effect of clinical dextran and re-infusion of autologous blood].
    Ikeda K; Tanaka S; Mizutani H; Horii D; Arai Y
    Masui; 1971 Jul; 20(7):639-47. PubMed ID: 5105401
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical comparison of hetastarch and albumin in postoperative cardiac patients.
    Diehl JT; Lester JL; Cosgrove DM
    Ann Thorac Surg; 1982 Dec; 34(6):674-9. PubMed ID: 6184023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of a new plasma expander, hydroxyethyl starch. 2. Study of its effects on serum enzymes, liver function, erythrocyte sedimentation and kidney function and evaluation of its adverse effects].
    Amakata Y; Hara M; Umemoto Y; Tanaka K; Kosaki G
    Masui; 1972 Jan; 21(1):40-5. PubMed ID: 5063390
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hydroxyethyl starch].
    Wierre F; Robin E; Barreau O; Vallet B
    Ann Fr Anesth Reanim; 2010; 29(7-8):543-51. PubMed ID: 20620014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulopathy induced by hydroxyethyl starch.
    Baldassarre S; Vincent JL
    Anesth Analg; 1997 Feb; 84(2):451-3. PubMed ID: 9024047
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of hydroxyethyl starch (HES)].
    Kobayashi K; Takagi Y; Tanifuji Y; Sugahara Y
    Masui; 1971 Sep; 20(10):950-1. PubMed ID: 5166808
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial.
    Rasmussen KC; Johansson PI; Højskov M; Kridina I; Kistorp T; Thind P; Nielsen HB; Ruhnau B; Pedersen T; Secher NH
    Ann Surg; 2014 Feb; 259(2):249-54. PubMed ID: 24100337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of in vitro experiments on hydroxyethyl starch solutions.
    Scharbert G; Kozek-Langenecker S
    Anesth Analg; 2007 Sep; 105(3):885; author reply 885-6. PubMed ID: 17717268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.